Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival
Open Access
- 31 March 2011
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 17 (7) , 1741-1752
Abstract
Purpose: Given that nerve growth factor has previously been shown to be involved in breast cancer progression, we have tested here the hypothesis that the other neurotrophins (NT) are expressed and have an influence in breast tumor growth.Keywords
All Related Versions
This publication has 40 references indexed in Scilit:
- OnTrk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer BiologyClinical Cancer Research, 2009
- Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferationOncogene, 2009
- Developmental and Lactational Exposure to Dieldrin Alters Mammary Tumorigenesis in Her2/neu Transgenic MicePLOS ONE, 2009
- Endogenous Truncated TrkB.T1 Receptor Regulates Neuronal Complexity and TrkB Kinase Receptor FunctionIn VivoJournal of Neuroscience, 2009
- Dieldrin promotes resistance to anoikis in breast cancer cells in vitroReproductive Toxicology, 2008
- A Role for Glial Cell–Derived Neurotrophic Factor–Induced Expression by Inflammatory Cytokines and RET/GFRα1 Receptor Up-regulation in Breast CancerCancer Research, 2007
- Manipulation of the nerve growth factor network in prostate cancerExpert Opinion on Investigational Drugs, 2007
- The yin and yang of neurotrophin actionNature Reviews Neuroscience, 2005
- Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancerFEBS Letters, 2004
- Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: Expression patterns and effects onIn vitro invasive behaviorInternational Journal of Cancer, 1999